<unk>  is reported to increase VEGF, a signal protein that can activate tumor growth and also is considered to cause pulmonary hypertension. In phase 3 trial conducted at 29 sites in China,<unk>  treatment was found to cause hyperkalemia, i.e., increase in serum potassium, and metabolic acidosis in patients.
Roxadustat
Azelastine
Eliglustat
Lifitegrast
Mibolerone
Montelukast
Seratrodast
Pemirolast